| 2019 |
TAF5L and TAF6L are components/co-activators of GNAT-HAT (PCAF/SAGA) complexes in mouse ESCs and transcriptionally activate c-Myc and Oct4 and their corresponding MYC and CORE regulatory networks, primarily through H3K9ac deposition and c-MYC recruitment, thereby maintaining self-renewal. |
CRISPR-Cas9 loss-of-function screen, ChIP-seq (H3K9ac), RNA-seq, and molecular epistasis in mouse ESCs |
Molecular cell |
High |
31005419
|
| 2026 |
TAF5L (together with TADA1 and TAF6L) is a non-enzymatic SAGA CORE module subunit required for KAT2A protein stability; loss of TAF5L disrupts SAGA complex integrity, releasing non-chromatin-bound KAT2A that is degraded by the proteasome (via E3 ligase UBR5 and deubiquitinase OTUD5), resulting in reduced H3K9 acetylation. |
Fluorescence-based KAT2A stability reporter, CRISPR knockouts, proteomic profiling, focused CRISPR screen of ubiquitin-proteasome system genes |
Nature communications |
High |
42009663
|
| 2026 |
High-resolution cryo-EM structure of endogenous human SAGA reveals that TAF5L and TAF6L contain major structural differences from their canonical TFIID paralogs (TAF5 and TAF6); TAF6L HEAT repeat domain provides a docking surface for the metazoan-specific splicing-factor module (SPL), and these structural rearrangements in TAF5L/TAF6L are directly required to accommodate SPL within the SAGA complex. |
Cryo-EM structure of affinity-ligand-purified endogenous human SAGA complex |
Science advances |
High |
41849588
|
| 2025 |
Loss of Taf5l in hematopoietic stem and progenitor cells strongly inhibits hematopoiesis in vivo, causing a buildup of immature hematopoietic cells in the bone marrow, associated with upregulation of interferon pathway genes, reduced mitochondrial activity, and increased megakaryocyte progenitor commitment; loss also enhances cell outgrowth and interferon pathway in a human MDS model. |
Genome-wide in vivo CRISPR knockout screen in HSPCs, bone marrow analysis, transcriptomic profiling |
Nature communications |
High |
40475452 41577693
|
| 2006 |
TAF5L is preferentially expressed in testis and ovary during gametogenesis and embryogenesis in frogs; in vitro protein-DNA interaction assays demonstrated that TAF5L can participate in core promoter complexes as part of variant TAF-containing assemblies, consistent with a role in germ cell-specific transcription initiation. |
RT-PCR, in situ hybridization, in vitro protein-DNA interaction assays with recombinant proteins |
Gene expression patterns : GEP |
Medium |
16412700
|
| 2019 |
In the clam Meretrix petechialis, MpTAF5L interacts with the transcription factor MpMITF (via the N-terminal TAF5-NTD2 domain of MpTAF5L) and enhances MpMITF transcriptional activation activity; knockdown of MpTAF5L decreased expression of the MITF target gene MpBcl-2 without changing MpMITF mRNA levels, indicating coactivator function. |
Yeast two-hybrid assay, domain mapping, siRNA knockdown with target gene expression analysis |
Fish & shellfish immunology |
Medium |
31743760
|
| 2026 |
Lentiviral transduction of TAF5L in CD8+ Tregs boosted FOXP3 expression and was sufficient to enhance the suppressive function of these cells, identifying TAF5L as a molecular regulator of CD8+ Treg stability and function. |
Lentiviral transduction of TAF5L into primary human CD8+ Tregs, in vitro suppression assays, flow cytometry |
European journal of immunology |
Medium |
41630158
|
| 2025 |
High-resolution cryo-EM structure of endogenous human SAGA (preprint version) shows that TAF5L and TAF6L structural differences from canonical TFIID paralogs are directly implicated in structural rearrangements required to accommodate the SPL splicing-factor module; SPL binds SAGA through a smaller interface than in U2snRNP, sharing a deeply inserted helical motif. |
Cryo-EM structure of affinity-ligand-purified endogenous human SAGA |
bioRxivpreprint |
Medium |
|